MedPath

Maxivent

Brand Name: Maxivent

Generic Name: Doxofylline

Active
Registration Number

DR-XY48596

Dosage Form

Tablet

Issuance Date

February 2, 2023

Expiry Date

February 2, 2028

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength400 mg
PackagingAlu/Amber PVC Blister Pack x 10's (Box of 3 blister packs x 10 tablets)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Drug for Obstructive Airway Disease (Xanthine)
A
Application
Initial
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

DoxofyllineActive
Monograph: Doxofylline

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform